Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)
Terminated
- Conditions
- Indolent Non Hodgkin's Lymphoma (iNHL)Chronic Lymphocytic Leukaemia (CLL)
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Astellas Pharma International B.V.
- Target Recruit Count
- 25
- Registration Number
- NCT02273856
- Locations
- π°πΌ
Site KW96501 Kuwait Cancer Control Center, Shuwaikh, Kuwait
π―π΄Site JO96201 King Abdullah University Hospital, Irbid, Jordan
π±π§Site Hammoud Hospital University Medical Center, Beirut, Lebanon
Β© Copyright 2025. All Rights Reserved by MedPath